Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities

Journal of Intellectual Disability Research

Volumn 55, Issue 2, 2011, Pages 199-209

  Charlot, L ^a   Abend, S ^b   Ravin, P ^a   Mastis, K ^a   Hunt, A ^c   Deutsch, C ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Healthcare Quality Managment Group   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aggressive behavior; Intellectual disabilities; Psychoactive medications

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; DIURETIC AGENT; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPOCHOLESTEROLEMIC AGENT; INSULIN; METOCLOPRAMIDE; OXYBUTYNIN; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TOLTERODINE; WARFARIN;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; AUTISM; BEHAVIOR DISORDER; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; CONSTIPATION; COST BENEFIT ANALYSIS; DEMENTIA; DOWN SYNDROME; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEARING LOSS; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; HYPOTHYROIDISM; INTELLECTUAL IMPAIRMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL PATIENT; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; OSTEOARTHRITIS; PREVALENCE; PSYCHOSIS; SLEEP APNEA SYNDROME;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; CONSTIPATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HOSPITALS, PSYCHIATRIC; HUMANS; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MENTAL RETARDATION; MENTALLY DISABLED PERSONS; MIDDLE AGED; NEEDS ASSESSMENT; PILOT PROJECTS; RESIDENTIAL FACILITIES; YOUNG ADULT;

EID: 78751558806     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/j.1365-2788.2010.01294.x     Document Type: Article

References (46)

1. Abend S. & Silka V. R. (1999) Medical care of patients with developmental disabilities. Mental Health Aspects of Developmental Disabilities 2, 170-7.
2. Baxter H., Lowe K., Houston H., Jones G., Felce D. & Kerr M. (2006) Previously unidentified morbidity in patients with intellectual disability. British Journal of General Practice 56, 93-8.
3. Beange H., McElduff A. & Baker W. (1995) Medical disorders of adults with mental retardation: a population study. American Journal on Mental Retardation 99, 595-604.
4. Bohmer C. J., Klinkenberg-Knol E. C., Niezen-de Boer M. C. & Meuwissen S. G. (2000) Gastroesophageal reflux disease in Intellectually Disabled individuals: how often, how serious, how manageable? The American Journal of Gatsroenterology 85, 1868-72.
5. Bohmer C. J., Taminiau J. A., Klinkenberg-Knol E. C. & Meuwissen S. G. (2001) The prevalence of constipation in institutionalized people with intellectual disability. Journal of Intellectual Disability Research 45, 212-18.
6. Bosch J., Van Dyke C., Smith S. M. & Poulton S. (1997) Role of medical conditions in the exacerbation of self injurious behavior: an exploratory study. Mental Retardation 35, 124-30.
7. Carr E., Smith C., Giacin T., Whelan B. & Pancari J. (2003) Menstrual discomfort as a biological setting event for severe problem behavior: assessment and intervention. American Journal on Mental Retardation 2, 117-33.
8. Carr E. G. & Owen-DeSchryer J. S. (2007) Physical illness, pain, and problem behavior in minimally verbal people with Developmental Disabilities. Journal of Autism and Developmental Disorders 37, 413-24.
9. Center for Developmental Disabilities Evaluation and Research (CDDER) (2005) Shriver Center, University of Massachusetts Medical School. MBHP Psychopharmacology Forum. March 10, 2005.
10. Cooper S. A. (1998) Clinical study of the effects of age on the physical health of adults with learning disabilities. American Journal on Mental Retardation 102, 582-9.
11. Cooper S. A., Melville C. A. & Morrison J. (2004) People with Intellectual Disabilities Their health needs differ and need to be recognized and met. British Medical Journal 329, 414-15.
12. Cooper S. A., Morrison J., Melville C., Finlayson J., Allan L., Martin G. et al. (2006) Improving the health of people with Intellectual Disabilities: outcomes of a health screening programme after 1 year. Journal of Intellectual Disability Research 50, 667-77.
13. Davidson P. W., Janicki L. P., Houser K., Henderson C. M. & Cain N. N. (2003) Age and metal health associations between behavioral disorders and health status among older adults with ID. Journal of Intellectual Disability Research 47, 424-30.
14. Deb S., Sohanpal R., Soni L., Lenotre L. & Unwin G. (2007) The effectiveness of antipsychotic medication in the management of behavior problems in adults with Intellectual Disabilities. Journal of Intellectual Disability Research 51, 766-77.
15. Felce D., Helen Baxter H., Lowe K., Dunstan F., Houston H., Jones G. et al. (2008) The impact of repeated health checks for adults with Intellectual Disabilities. Journal of Applied Research in Intellectual Disabilities 21, 585-96.
16. Gardner W. & Whalen J. (1996) Discussion: a multimodal analytic model for evaluating the effects of medical problems on nonspecific behavioral symptoms in persons with developmental disabilities. Behavioral Interventions 11, 147-61.
17. Griebling T. L. (2007) Urinary tract infection in men. In: Urologic Diseases in America DHHS, PHS, NIH, NIDDK (eds M. S. Litwin & C. S. Saigal ), pp. 621-45. GPO, Washington, DC. NIH publication 07-5512.
18. Gunsett R., Mulick J., Fernald W. & Martin J. (1989) Brief report: indications for medical screening prior to behavioral programming for severely and profoundly mentally retarded clients. Journal of Autism and Developmental Disorders 19, 167-72.
19. Hovstadius B., Åstrand B. & Petersson G. (2009) Dispensed drugs and multiple medications in the Swedish population: an individual-based register study. BMC Clinical Pharmacology 9, 1-10.
20. Jones D. R., Macias C., Barreira P. J., Fisher W. A., Hargeaves W. A. & Harding C. M. (2004) Prevalence, severity and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatric Services 55, 1250-7.
21. Jordon S., Tunnicliffe C. & Sykes A. (2002) Minimizing side-effects: the clinical impact of nurse-administered 'side effect' checklists. Journal of Advanced Nursing 37, 155-65.
22. Kennedy C., Juarez A. P., Greenslade K., Harvey M. T. & Tally B. (2007) Children with severe developmental disabilities and behavioral disorders have increased special healthcare needs. Developmental Medicine and Child Neurology 49, 926-30.
23. Kennedy C. H. & Meyer K. A. (1996) Sleep deprivation, allergy symptoms, and negatively reinforced problem behavior. Journal of Applied Behavior Analysis 29, 133-5.
24. Kozma C. & Mason S. (2003) Survey of nursing and medical profile prior to deinstitutionalization of a population with profound mental retardation. Clinical Nursing Research 12, 8-22.
25. Kroese B. S., Dewhurst D. & Holmes G. (2001) Diagnosis and drugs: help or hindrance when people with learning disabilities have psychological problems? British Journal of Learning Disabilities 29, 26-33.
26. Kwok H. & Cheung W. H. (2007) Co-mobidity of psychiatric disorder and medical illness in people with Intellectual Disabilities. Current Opinions in Psychiatry 20, 443-9.
27. Lennox N., Rey-Conde T. & Cooling N. (2006) Comprehensive health assessments during de institutionalization: an observational study. Journal of Intellectual Disability Research 50, 719-24.
28. Lennox N., Bain C., Rey-Conde T., Purdie D., Bush R. & Pandeya N. (2007) Effects of a comprehensive health assessment programme for Australian adults with intellectual disability: a cluster randomized trial. International Journal of Epidemiology 36, 139-46.
29. Lieberman J. A., Stroup T. S., McEvoy J. P., Swartz M. S., Rosenheck R. A., Perkins D. O. et al. (2007) Effectiveness of antipsychotic drugs inpatients with chronic schizophrenia. New England Journal of Medicine 353, 1209-23.
30. Mackin P., Bishop D., Watkinson H., Gallagher P. & Ferrier I. N. (2007) Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. British Journal of Psychiatry 191, 23-9.
31. Matson J. L. & Neal D. (2009) Psychotropic medication use for challenging behaviors in persons with Intellectual Disabilities: an overview. Research in Developmental Disabilities 30, 572-86.
32. Matthews T., Weston N., Baxter H., Felce D. & Kerr M. (2008) A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress. Journal of Intellectual Disability Research 52, 163-73.
33. Molloy C. & Manning-Courtney P. (2003) Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 7, 165-71.
34. Nikolov R. N., Bearss K. E., Lettinga J., Erickson C., Rodowski M., Aman M. G. et al. (2008) Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. Journal of Autism and Developmental Disorders 39, 405-13.
35. O'Reilly M. (1997) Functional analysis of episodic self-injury correlated with recurrent otitis media. Journal of Applied Behavioral Analysis 30, 165-7.
36. Patja K., Molsa P. & Livanainen M. (2001) Cause-specific mortality of people with intellectual disability in a population based, 35 year follow-up study. Journal of Intellectual Disability Research 45, 40.
37. Roberts C., Yoder P. J. & Kennedy C. H. (2005) Descriptive analysis of epileptic seizures and problem behavior in adults with developmental disabilities. American Journal on Mental Retardation 110, 405-12.
38. Ryan R. & Sunada K. (1997) Medical evaluation of persons with mental retardation referred for psychiatric assessment. General Hospital Psychiatry 19, 274-80.
39. Skjeldal O. H., Sponheim E., Ganes T., Jellum E. & Bakke S. (1998) Childhood autism: the need for physical investigations. Brain & Development 20, 227-33.
40. Stolker J. J., Koedoot P. J., Heerdink E. R., Leufkens H. G. & Nolen W. A. (2002) Psychotropic drug use in intellectually disabled group home residents with behavioral problems. Pharmacopsychiatry 35, 19-23.
41. Thomas C., Hestermann U., Walther S., Pfueller U., Hack M., Oster P., Mundt C. & Weisbrod M. (2008) Prolonged activation EEG differentiates dementia with and without delirium in frail elderly patients. Journal of Neurology, Neurosurgery & Psychiatry 79, 119-25.
42. Tsakanikos E., Costello H., Holt G., Strumey P. & Bouras N. (2007) Behaviour management problems as predictors of psychotropic medication use of psychiatric services in adults with autism. Journal of Developmental Disorders 37, 1080-5.
43. Valdovinos M. G., Caruso M., Roberts C., Kim G. & Kennedy C. H. (2005) Medical and behavioral symptoms as potential medication side effects in adults with developmental disabilities. American Journal of Mental Retardation 110, 164-70.
44. van Allen M. I., Fung J. & Jurenka S. B. (1999) Health care concerns and guidelines for adults with Down syndrome. American Journal of medical genetics 89, 100-10.
45. Veugelers R., Penning C., Rieken R., Merkus P., Arets H., Bernsen R. et al. (2006) Clinical aspects of constipation in children with severe generalized cerebral palsy in the Netherlands. Journal of Applied Research in Intellectual Disabilities 19, 261.
46. Woo B., Daly J., Allen E., Jeste D. & Sewell D. (2003) Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. Journal of Geriatric Psychiatry and Neurology 16, 121-5.